Le Conte Wealth Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History
Le Conte Wealth Management, LLC
- $150 Billion
- Q3 2025
A detailed history of Le Conte Wealth Management, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Le Conte Wealth Management, LLC holds 526 shares of ALNY stock, worth $236,258. This represents 0.16% of its overall portfolio holdings.
Number of Shares
526Holding current value
$236,258% of portfolio
0.16%Shares
1 transactions
Others Institutions Holding ALNY
# of Institutions
886Shares Held
115MCall Options Held
1.27MPut Options Held
1.25M-
Capital World Investors Los Angeles, CA16.4MShares$7.38 Billion1.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.6MShares$6.09 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$4.29 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.22MShares$3.24 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY4.54MShares$2.04 Billion0.14% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $55.3B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...